glutathion liposomal belgique Liposomé Glutathion Liposomal - 60 gélules
Description
Approximately 2050 % of patients with SLE and 75 % of patients with RA eventually have cessation of the drug by 610 years of follow-up, mainly because of inefficacy in the case of RA and because of disease remission in the case of SLE [97, 115, 125, 128, 129]
Human data: two healthy adults tolerated 20 mg IV without adverse events (Lee & Burgess, 2025) the only formal human safety data
Uchiyama M, Hamamura M, Kuwano T, et al
A.GrantM.KuskowskiM.SchneiderJ
